Mission & Quality Statement

Mission Statement

The Molecular Research Laboratory (MRL) of the Malaysian Liver Foundation is dedicated to molecular diagnostics and research for accuracy in diagnosis and assessment of effectiveness of treatment and prevention of diseases of the liver, gallbladder and pancreas by providing reliable, reproducible and timely services.

 

Quality Statement

The Molecular Research Laboratory (MRL) is accredited under the accreditation scheme of the National Association of Testing Authorities, Australia and the Royal College of Pathologists of Australasia. All tests at MRL have been performed in accordance with NATA requirements which include the requirements of ISO 15189:2007 and are traceable to national standards of measurement.

 

The MRL Quality Assurance Programme is implemented to create a dynamic system of procedures and protocols that assure the quality of laboratory services rendered.

 

Research & Clinical Trials

Research

Research

Hepatitis A Seroprevalence Study in 2000 with 2400 subjects

Seroprevalence of BsAg and HBsAb among children in Johor in 2001, collaboration with MOH

Antenatal screening study

Molecular Screening Services National Launch 2008

Nexavar Patient Asistance Program (NexPAP), 2009

Sponsor

Aventis Pasteur

MLF

Aventis Pasteur

InfoValley

Bayer

Clinical Trials

Clinical Trials

Pharmacine Trial (TH-HBV-012)

 

 

 

 

Organon Trial E-1696

 

 

  1. HCV G2/3 Study
  2. HCV Dialysis Study

Referral Lab

  1. Centre for Vaccinology, Gent Belgium
  2. Laboratory of The Institute for Clinical Pharmacology,
    The Netherlands
  3. Gribbles Pathology

 

  1. Institute for Medical Research
  2. Gribbles Pathology

 

  1. Gribbles Pathology

Sponsor

GlaxoSmithKline

 

 

 

 

Organon

 

 

Schering Plough

Clinical Trials

ROCHE Clinical study PROTOCOL BV 16209 C

Bristol-Myers Squibb Hepatitis Evaluation Project (HEP)

HEPAR-P Study

Sponsor

ROCHE

Bristol-Myers Squibb

Nova Labs

Clinical Trials

Organon Trial E-1696



ROCHE Clinical study
Peginterferon alfa-2a (BV 16209 C)

HCV G2/3 Study


HEPAR-P Study

Description

A multi-centre, double blind, randomised trial to compare the effects of nandrolone decanote and placebo on body composition and body weight in HIV-positive men with mild to moderate wasting, with Sustanon 250 as active reference treatment.

Pegylated Interferon Monotherapy and Combination therapy for patients with chronic
Hepatitis C

Comparison of three regimens of PEG-Intron plus Ribavirin in the treatment of chronic Hepatitis C, genotype 2 or 3, in previously untreated patients

Randomised double blind placebo controlled study to assess the efficacy, safety and antiviral activity of Phyllanthus niruri (HEPAR-P) in patients with chronic Hepatitis B

MALAYSIAN LIVER FOUNDATION © 2015 All Rights Reserved